DiaMedica Therapeutics Inc.
NASDAQ:DMAC
4.43 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.161 | 0.026 | 0.026 | 0.034 |
| Cost of Revenue
| 0.03 | 0.025 | 0.024 | 0.021 | 0.021 | 0 | 0.004 | 0.002 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.03 | -0.025 | -0.024 | -0.021 | -0.021 | 0.5 | -0.004 | -0.002 | -0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.161 | 0.026 | 0.026 | 0.034 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 13.11 | 7.839 | 8.765 | 8.31 | 7.9 | 4.522 | 3.206 | 1.763 | 0.886 | 3.713 | 3.781 | 5.208 | 2.327 | 0.804 | 1.366 | 1.04 | 1.067 | 0.617 | 0.023 | 0.462 |
| General & Administrative Expenses
| 7.961 | 6.162 | 4.881 | 4.389 | 3.693 | 2.739 | 1.313 | 0.718 | 0.423 | 1.121 | 2.539 | 2.532 | 2.079 | 1.296 | 1.005 | 0.619 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.157 | 6.162 | 4.881 | 4.389 | 3.693 | 2.739 | 1.313 | 0.718 | 0.423 | 1.121 | 2.539 | 2.532 | 2.079 | 1.296 | 1.005 | 0.619 | 1.385 | 0.192 | 0.178 | 0.169 |
| Other Expenses
| 0 | 0.353 | 0.082 | -0.205 | -0.856 | -0.068 | 0.006 | 0.222 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0.007 | -0.005 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 21.267 | 14.001 | 13.646 | 12.494 | 10.737 | 6.047 | 4.275 | 2.481 | 1.309 | 4.834 | 7.427 | 10.106 | 6.709 | 3.843 | 2.4 | 1.685 | 2.47 | 0.813 | 0.229 | 0.637 |
| Operating Income
| -21.267 | -14.001 | -13.646 | -12.699 | -11.593 | -6.761 | -4.519 | -2.481 | -1.309 | -4.834 | -7.427 | -10.106 | -6.709 | -3.843 | -2.4 | -1.685 | -2.31 | -0.787 | -0.203 | -0.603 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -13.522 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.38 | -30.587 | -7.906 | -17.81 |
| Total Other Income Expenses Net
| 1.929 | 0.353 | 0.082 | 0.434 | 0.975 | -0.107 | 0.015 | 0.332 | 0.003 | 0.052 | 0.019 | 0.016 | 0.062 | -0.423 | -0.035 | -0.168 | -0.003 | 0 | 0.01 | 0.033 |
| Income Before Tax
| -19.338 | -13.648 | -13.564 | -12.265 | -10.618 | -5.654 | -4.26 | -2.201 | -1.43 | -4.775 | -7.411 | -10.052 | -6.608 | -4.266 | -2.435 | -1.854 | -2.313 | 0 | -0.193 | -0.57 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -11.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.402 | 0 | -7.505 | -16.828 |
| Income Tax Expense
| 0.043 | 0.028 | 0.028 | 0.027 | 0.031 | 0.08 | -0.009 | 0.022 | 0.012 | 0.042 | 0.008 | 0.003 | 0.013 | 0.499 | 0.042 | 0.163 | 0.02 | -0.009 | 0.018 | 0.07 |
| Net Income
| -19.381 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 | -4.26 | -2.223 | -1.443 | -4.818 | -7.411 | -10.052 | -6.608 | -4.266 | -2.435 | -1.854 | -2.333 | -0.778 | -0.211 | -0.64 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -11.468 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.528 | -30.23 | -8.201 | -18.89 |
| EPS
| -0.6 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 | -0.4 | -1.55 | -2.71 | -4.11 | -2.93 | -2.98 | -2.54 | -2.04 | -2.91 | -0.89 | -0.5 | -2.35 |
| EPS Diluted
| -0.6 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 | -0.4 | -1.55 | -2.71 | -4.11 | -2.93 | -2.98 | -2.54 | -2.04 | -2.91 | -0.89 | -0.5 | -2.35 |
| EBITDA
| -21.237 | -13.976 | -13.622 | -12.473 | -10.716 | -5.493 | -4.28 | -2.26 | -1.385 | -4.831 | -6.315 | -7.699 | -4.354 | -1.677 | -2.328 | -1.495 | -2.291 | -0.784 | -0.175 | -0.597 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -10.986 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.266 | -30.458 | -6.809 | -17.621 |